DK0695193T3 - Transdermale aktivstof-præparater - Google Patents

Transdermale aktivstof-præparater

Info

Publication number
DK0695193T3
DK0695193T3 DK94915529T DK94915529T DK0695193T3 DK 0695193 T3 DK0695193 T3 DK 0695193T3 DK 94915529 T DK94915529 T DK 94915529T DK 94915529 T DK94915529 T DK 94915529T DK 0695193 T3 DK0695193 T3 DK 0695193T3
Authority
DK
Denmark
Prior art keywords
pct
active substance
transdermal active
substance preparations
sec
Prior art date
Application number
DK94915529T
Other languages
English (en)
Inventor
Wilfried Fischer
Thomas Struengmann
Original Assignee
Hexal Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hexal Ag filed Critical Hexal Ag
Application granted granted Critical
Publication of DK0695193T3 publication Critical patent/DK0695193T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK94915529T 1993-04-23 1994-04-22 Transdermale aktivstof-præparater DK0695193T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4313402A DE4313402A1 (de) 1993-04-23 1993-04-23 Transdermale Wirkstoffzubereitung
PCT/EP1994/001259 WO1994025069A1 (de) 1993-04-23 1994-04-22 Transdermale wirkstoffzubereitung

Publications (1)

Publication Number Publication Date
DK0695193T3 true DK0695193T3 (da) 1999-09-20

Family

ID=6486248

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94915529T DK0695193T3 (da) 1993-04-23 1994-04-22 Transdermale aktivstof-præparater

Country Status (13)

Country Link
US (1) US5738869A (da)
EP (1) EP0695193B1 (da)
JP (1) JP4334613B2 (da)
AT (1) ATE176593T1 (da)
AU (1) AU6721094A (da)
DE (2) DE4313402A1 (da)
DK (1) DK0695193T3 (da)
ES (1) ES2130420T3 (da)
FI (1) FI114444B (da)
GR (1) GR3029963T3 (da)
NO (1) NO311919B1 (da)
WO (1) WO1994025069A1 (da)
ZA (1) ZA942848B (da)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19517145C2 (de) * 1995-05-10 2000-02-24 Hexal Pharmaforschung Gmbh Transdermales therapeutisches System (TTS) zur Verabreichung von Testosteron
US6623752B1 (en) * 1996-07-02 2003-09-23 Hexal Ag Patch for transdermal application for pergolid
DE19641259A1 (de) * 1996-10-07 1998-04-16 Kade Pharma Fab Gmbh Arzneimittel auf Basis von Diclofenac
CN1072482C (zh) * 1996-11-08 2001-10-10 山东医科大学 低分子肝素脂质体喷胶剂及制备工艺
US20010003580A1 (en) * 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
DE19945522A1 (de) * 1999-09-23 2001-04-05 Hexal Ag Pharmazeutisches, wirkstoffhaltiges Gel
BR0001144B1 (pt) * 2000-02-21 2013-10-22 Composicão farmacêutica de diclofenaco à base de vitamina-e, papaína e hialuronidase
DE10053397A1 (de) * 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
DE10043321B4 (de) * 2000-08-24 2005-07-28 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung
DE10064453A1 (de) * 2000-12-16 2002-07-04 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
DE10137082A1 (de) * 2001-07-28 2003-02-13 Hexal Ag Matrixkontrolliertes transdermales therapeutisches System zur Anwendung von Pramiprexol und Ropinirol
US20040224010A1 (en) * 2002-11-15 2004-11-11 Optime Therapeutics, Inc. Ophthalmic liposome compositions and uses thereof
US6936273B2 (en) * 2002-12-20 2005-08-30 Idexx Laboratories, Inc. Liposomal analgesic formulation and use
EP1572152B1 (en) * 2002-12-20 2008-02-13 Idexx Laboratories, Inc. Liposomal analgesic formulation comprising diclofenac and its use for treatment of horses
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
EP1811935B1 (en) 2004-09-28 2016-03-30 Atrium Medical Corporation Heat cured gel and method of making
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
MX2007012121A (es) * 2005-03-31 2007-11-20 Unilever Nv Entrega intensificada de agentes de beneficio para la piel.
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
DK2086504T3 (da) 2006-10-17 2014-04-07 Nuvo Res Inc Diclofenac-gel
JP5371235B2 (ja) * 2006-12-06 2013-12-18 ロート製薬株式会社 皮膚外用剤
WO2009101412A1 (en) * 2008-02-13 2009-08-20 Cipla Limited Topical pharmaceutical composition
US8618164B2 (en) 2009-03-31 2013-12-31 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
EP2387391B1 (de) * 2009-07-24 2017-01-11 MIKA Pharma Gesellschaft für die Entwicklung und Vermarktung pharmazeutischer Produkte mbH Verfahren zur entwicklung einer als schaum auf die haut zu applizierenden flüssigen zusammensetzung sowie eine topisch applizierbare zusammensetzung
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
US10322213B2 (en) 2010-07-16 2019-06-18 Atrium Medical Corporation Compositions and methods for altering the rate of hydrolysis of cured oil-based materials
DE102013004199A1 (de) * 2012-05-15 2013-11-21 Mika Pharma Gesellschaft Für Die Entwicklung Und Vermarktung Pharmazeutischer Produkte Mbh Pharmazeutische Zusammensetzung
US20130309215A1 (en) * 2012-05-15 2013-11-21 Mika Pharma Gesellschaft Fur Die Entwicklung Und Vermarktung Pharmazeutischer Produkte Mbh Pharmaceutical composition
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
JP6449554B2 (ja) * 2014-03-30 2019-01-09 小林製薬株式会社 外用医薬組成物
EP4154915A1 (en) 2014-12-31 2023-03-29 Lantheus Medical Imaging, Inc. Lipid-encapsulated gas microsphere compositions and related methods
JP6542006B2 (ja) * 2015-03-31 2019-07-10 小林製薬株式会社 外用医薬組成物
KR20180133527A (ko) 2016-05-04 2018-12-14 랜티우스 메디컬 이메징, 인크. 초음파 조영제의 제조 방법 및 장치
US9789210B1 (en) 2016-07-06 2017-10-17 Lantheus Medical Imaging, Inc. Methods for making ultrasound contrast agents
BR112019007325A2 (pt) * 2016-10-18 2019-07-02 Lts Lohmann Therapie Systeme Ag sistema terapêutico tópico de duas camadas
US20250099369A1 (en) 2023-09-27 2025-03-27 Andros Pharmaceuticals Co., Ltd. Topical delivery compositions comprising non-steroidal anti-inflammatory drugs

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2374910A1 (fr) * 1976-10-23 1978-07-21 Choay Sa Preparation a base d'heparine, comprenant des liposomes, procede pour l'obtenir et medicaments contenant de telles preparations
US4439432A (en) * 1982-03-22 1984-03-27 Peat Raymond F Treatment of progesterone deficiency and related conditions with a stable composition of progesterone and tocopherols
FR2548021B1 (fr) * 1983-06-29 1986-02-28 Dick P R Compositions pharmaceutiques dermiques a action prolongee et continue a base d'acides gras essentiels
DE3582439D1 (de) * 1984-01-28 1991-05-16 Roshdy Ismail Mittel zur behandlung von herzerkrankungen.
DE3402928A1 (de) * 1984-01-28 1985-08-08 Roshdy Dipl.-Chem. Dr. 5000 Köln Ismail Mittel zur behandlung von herzerkrankungen
US4612194A (en) * 1984-02-15 1986-09-16 Roshdy Ismail Anti-rheumatic agents and their use
EP0343694B1 (de) * 1984-03-07 1992-11-25 Roshdy Dr. Ismail Mittel zur Behandlung und zum Schutz der Haut
DE3507791A1 (de) * 1984-03-07 1985-09-26 Roshdy Ismail Mittel zum schutz der haut
DE3446873A1 (de) * 1984-12-21 1986-07-10 Merckle Gmbh Fluessige diclofenac-zubereitungen
DE3506881A1 (de) * 1985-02-27 1986-08-28 RODISMA pharmazeutische Produkte GmbH, 5000 Köln Vitamin e spray
CH666621A5 (de) * 1986-06-27 1988-08-15 Ciba Geigy Ag Topisch applizierbare pharmazeutische zusammensetzungen mit systemischer wirkung.
US4745107A (en) * 1986-08-20 1988-05-17 Foley Kevin M Heparin derivatives with improved permeability
US4745105A (en) * 1986-08-20 1988-05-17 Griffin Charles C Low molecular weight heparin derivatives with improved permeability
US5023084A (en) * 1986-12-29 1991-06-11 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
IT1229489B (it) * 1988-12-09 1991-09-03 Altergon Sa Composizioni farmaceutiche lipidiche per uso topico atte a veicolare un principio attivo antiinfiammatorio idrosolubile
DE3904674A1 (de) * 1989-02-16 1990-08-23 Cassella Ag Verwendung einer wirkstoffkombination zur behandlung rheumatischer erkrankungen
DE3908047A1 (de) * 1989-03-13 1990-09-20 Desitin Arzneimittel Gmbh Hochdisperse pharmazeutische zusammensetzung
EP0576605A4 (en) * 1991-03-19 1994-06-08 Vithal J Rajadhyaksha Compositions and method comprising aminoalcohol derivatives as membrane penetration enhancers
US5498420A (en) * 1991-04-12 1996-03-12 Merz & Co. Gmbh & Co. Stable small particle liposome preparations, their production and use in topical cosmetic, and pharmaceutical compositions

Also Published As

Publication number Publication date
NO954215D0 (no) 1995-10-20
ATE176593T1 (de) 1999-02-15
JP4334613B2 (ja) 2009-09-30
FI954990L (fi) 1995-11-23
US5738869A (en) 1998-04-14
FI114444B (fi) 2004-10-29
EP0695193B1 (de) 1999-02-10
DE4313402A1 (de) 1994-10-27
EP0695193A1 (de) 1996-02-07
WO1994025069A1 (de) 1994-11-10
JPH08509715A (ja) 1996-10-15
ES2130420T3 (es) 1999-07-01
DE59407810D1 (de) 1999-03-25
NO954215L (no) 1995-12-14
FI954990A0 (fi) 1995-10-19
ZA942848B (en) 1995-10-25
AU6721094A (en) 1994-11-21
GR3029963T3 (en) 1999-07-30
NO311919B1 (no) 2002-02-18

Similar Documents

Publication Publication Date Title
DK0695193T3 (da) Transdermale aktivstof-præparater
ATE140612T1 (de) Depigmentierendes mittel zur gleichzeitigen behandlung von hautoberschichten und hauttiefschichten
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
DK0948965T3 (da) Stabile medicinske præparater indeholdende 4,5-epoxymorphinanderivater
DK1037634T3 (da) Oral administrationsform som omfatter en protonpumpeinhibitor (fx pantoprazo)
NO952981D0 (no) Höyopplöselige flerkomponent-innleiringskomplekser inneholdende et basisk medikament, en syre og et cyklodekstrin
AU2001236744A1 (en) Delivery system for topical skin care agents
GR3033301T3 (en) Medicament form for the delivery of active substances to wounds
AU3611299A (en) Use of metalloprotinease inhibitors for inducing and/or stimulating growth of hair or hairs and/or for slowing down their loss
FI962220A0 (fi) Transdermaalinen terapeuttinen järjestelmä
MXPA03011825A (es) Combinacion de ingrediente activo para tratar una dependencia de sustancias aditivas o narcoticas utilizando medicamentos.
DK0625898T3 (da) Liposom-piroxicamformuleringer
NZ308516A (en) Transdermal therapeutic system (tts) for administering testosterone
GR3023962T3 (en) Drugs containing diphosphonic acids and salts thereof.
ES2169126T3 (es) Composicion que contiene retinal.
AU2381402A (en) Small acid-soluble spore protein and uses thereof
GR3030954T3 (en) Children-proof package for active substance-containing plaster
ATE211383T1 (de) Topische aciclovir-zubereitung
ES2122005T3 (es) Medicamento que contiene (-)-metrifonato.
CO4600680A1 (es) Procedimientos para la prevencion de la degradacion de la proteina c
FI964448A0 (fi) Uusi biologisesti aktiivinen peptidi ja sen valmistus
AR034767A1 (es) Combinacion de principios activos para la terapia medicinal de la dependencia a la nicotina.
PT932408E (pt) FORMULACOES FARMACEUTICAS E COSMéTICAS COM ACTIVIDADES ANTIMICROBIANA